Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes (Q43028452)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 May 2010
edit
Language Label Description Also known as
English
Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes
scientific article published on 24 May 2010

    Statements

    Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes (English)
    Hideaki Nakatsuji
    Ken Kishida
    Iichiro Shimomura
    Senri Study II Group
    24 May 2010
    243-245

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit